DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,640,862 | -14.9% | 115,440 | -17.7% | 0.29% | -8.0% |
| Q2 2023 | $33,648,734 | -32.1% | 140,203 | -28.7% | 0.31% | -36.7% |
| Q1 2023 | $49,577,177 | -17.2% | 196,704 | -12.8% | 0.49% | -21.0% |
| Q4 2022 | $59,904,867 | +6.3% | 225,698 | +3.4% | 0.62% | -3.0% |
| Q3 2022 | $56,360,000 | +4.1% | 218,206 | +2.2% | 0.64% | +10.3% |
| Q2 2022 | $54,143,000 | -8.3% | 213,565 | +6.1% | 0.58% | +6.8% |
| Q1 2022 | $59,015,000 | -1.5% | 201,192 | +10.5% | 0.55% | +0.2% |
| Q4 2021 | $59,930,000 | +39.3% | 182,155 | +28.9% | 0.54% | +26.7% |
| Q3 2021 | $43,016,000 | +141.2% | 141,298 | +112.7% | 0.43% | +141.6% |
| Q2 2021 | $17,831,000 | +52.6% | 66,442 | +28.0% | 0.18% | +26.2% |
| Q1 2021 | $11,682,000 | +0.3% | 51,903 | -1.0% | 0.14% | -7.2% |
| Q4 2020 | $11,647,000 | +2.7% | 52,433 | -0.5% | 0.15% | -8.4% |
| Q3 2020 | $11,346,000 | +26.5% | 52,691 | +3.9% | 0.17% | +16.9% |
| Q2 2020 | $8,971,000 | +11.8% | 50,729 | -12.5% | 0.14% | -5.3% |
| Q1 2020 | $8,026,000 | -17.0% | 57,993 | -7.9% | 0.15% | +2.7% |
| Q4 2019 | $9,668,000 | +2.5% | 62,997 | -3.5% | 0.15% | -3.9% |
| Q3 2019 | $9,428,000 | -8.8% | 65,273 | -9.7% | 0.15% | -8.4% |
| Q2 2019 | $10,335,000 | +2.5% | 72,323 | -5.3% | 0.17% | -0.6% |
| Q1 2019 | $10,080,000 | +34.7% | 76,355 | +5.2% | 0.17% | +24.6% |
| Q4 2018 | $7,485,000 | -2.3% | 72,578 | +3.0% | 0.13% | +11.7% |
| Q3 2018 | $7,658,000 | +6.6% | 70,483 | -3.2% | 0.12% | +0.8% |
| Q2 2018 | $7,187,000 | +2.2% | 72,835 | +1.4% | 0.12% | +1.7% |
| Q1 2018 | $7,034,000 | -17.8% | 71,844 | -22.1% | 0.12% | -14.6% |
| Q4 2017 | $8,556,000 | +9.5% | 92,175 | +1.2% | 0.14% | +3.8% |
| Q3 2017 | $7,813,000 | +2.0% | 91,094 | +0.4% | 0.13% | -1.5% |
| Q2 2017 | $7,658,000 | -4.3% | 90,754 | -3.0% | 0.13% | -5.6% |
| Q1 2017 | $8,004,000 | -6.7% | 93,591 | -15.1% | 0.14% | -9.0% |
| Q4 2016 | $8,580,000 | -1.5% | 110,211 | -0.8% | 0.16% | -3.7% |
| Q3 2016 | $8,710,000 | +187.1% | 111,103 | +269.8% | 0.16% | +113.2% |
| Q2 2016 | $3,034,000 | -3.6% | 30,044 | -19.0% | 0.08% | -1.3% |
| Q1 2016 | $3,148,000 | +5.6% | 37,080 | +15.6% | 0.08% | +2.7% |
| Q4 2015 | $2,981,000 | +5.9% | 32,086 | -2.9% | 0.08% | +1.4% |
| Q3 2015 | $2,814,000 | -4.9% | 33,031 | -4.5% | 0.07% | +2.8% |
| Q2 2015 | $2,960,000 | -6.0% | 34,587 | -6.7% | 0.07% | -6.5% |
| Q1 2015 | $3,148,000 | -5.2% | 37,080 | -4.3% | 0.08% | -2.5% |
| Q4 2014 | $3,321,000 | +7.0% | 38,750 | -5.1% | 0.08% | +23.4% |
| Q3 2014 | $3,104,000 | -5.4% | 40,841 | -2.0% | 0.06% | -1.5% |
| Q2 2014 | $3,281,000 | +3.6% | 41,674 | -1.3% | 0.06% | +6.6% |
| Q1 2014 | $3,166,000 | -4.4% | 42,210 | -1.6% | 0.06% | -29.9% |
| Q4 2013 | $3,310,000 | +11.1% | 42,876 | -0.3% | 0.09% | -2.2% |
| Q3 2013 | $2,980,000 | +7.6% | 43,002 | -1.7% | 0.09% | +3.5% |
| Q2 2013 | $2,769,000 | +32.0% | 43,740 | +29.6% | 0.09% | +28.4% |
| Q1 2013 | $2,098,000 | +9.7% | 33,748 | -1.3% | 0.07% | 0.0% |
| Q4 2012 | $1,912,000 | -1.3% | 34,209 | -2.7% | 0.07% | -1.5% |
| Q3 2012 | $1,938,000 | -11.4% | 35,154 | -16.3% | 0.07% | -15.0% |
| Q2 2012 | $2,188,000 | -11.6% | 42,012 | -5.0% | 0.08% | -9.1% |
| Q1 2012 | $2,475,000 | +19.8% | 44,203 | +0.6% | 0.09% | +7.3% |
| Q4 2011 | $2,066,000 | +15.9% | 43,937 | +3.4% | 0.08% | +3.8% |
| Q3 2011 | $1,783,000 | -23.1% | 42,496 | -2.9% | 0.08% | -10.2% |
| Q2 2011 | $2,319,000 | -3.1% | 43,754 | -5.1% | 0.09% | -2.2% |
| Q1 2011 | $2,393,000 | -2.3% | 46,116 | -11.2% | 0.09% | -6.2% |
| Q4 2010 | $2,449,000 | +11.3% | 51,911 | -4.2% | 0.10% | +3.2% |
| Q3 2010 | $2,201,000 | +7.3% | 54,207 | -2.0% | 0.09% | -3.1% |
| Q2 2010 | $2,052,000 | -22.1% | 55,288 | +67.7% | 0.10% | -11.1% |
| Q1 2010 | $2,634,000 | -0.3% | 32,967 | -6.1% | 0.11% | -4.4% |
| Q4 2009 | $2,641,000 | -2.2% | 35,114 | -12.5% | 0.11% | -7.4% |
| Q3 2009 | $2,701,000 | +6.3% | 40,134 | -2.5% | 0.12% | -5.4% |
| Q2 2009 | $2,541,000 | +2.1% | 41,154 | -10.3% | 0.13% | -11.0% |
| Q1 2009 | $2,488,000 | – | 45,879 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |